- February 25, 2019
Systemic Administration Indications: uncomplicated and complicated infections caused by ciprofloxacin-sensitive microorganisms: respiratory infections; ENT infections; eye infections; Renal and urinary infections; Genital infections; infections of the gastrointestinal tract, biliary infections, peritonitis; Skin and soft tissue infections; infections of bones and joints; sepsis; infection or risk of infection (prophylaxis) in immunocompromised patients; Selective intestinal decontamination in immunosuppressed patients. Topical: corneal ulcers with Pseudomonas aeruginosa…
